Markus Puhlmann - 03 Mar 2025 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role: Chief Medical Officer
Signature: /s/ Markus Puhlmann by Chris Nenno, as Attorney-in-Fact
Issuer symbol: CATX
Transactions as of: 03 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2025, 16:29:57 UTC
Previous filing: 24 Jun 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CATX	Stock option (right to buy)	Award	$0	+165,000		$0.000000	165,000	03 Mar 2025	Common Stock	165,000	$2.46	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option grant was approved by the Compensation Committee of the Issuer's Board of Directors on February 13, 2025, with a grant date of March 3, 2025 (the "Grant Date"), and represents the Reporting Person's annual equity award for 2025.
F2	Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date.

Remarks:

Exhibit 24